Kraft Group Invests in Autism Diagnostic Co. SynapDx
March 28, 2013
The Kraft Group has made a significant investment in SynapDx, a laboratory diagnostic services company that focuses on autism and neurodevelopmental disorders. The funding will support clinical development of its blood-based autism spectrum disorder diagnostic test, which is designed to help clinicians identify children with autism earlier than they do today. Kraft's investment builds on SynapDx's recent fundraising momentum, including a $6 million round of financing in December 2012. Based in Foxborough, MA, The Kraft Group is a holding company for the Kraft family's various business interests, which include a portfolio of private equity investments.